Wall Street researchers used Claude to design drug candidates, and the trade is in the lab

Citrini Research and Anthropic tested Claude Science on scorpion antivenom, and the results point investors toward companies that run experiments A Wall Street research shop just tried its hand at drug discovery. It brought an AI model instead of a lab coat. Citrini Research, working with Anthropic , used the Claude Science model to hunt for potential scorpion antivenom candidates. The experiment produced roughly a year’s worth of early-stage design work in a matter of days. Then it produced something analysts care about even more: an investment thesis. Citrini’s analysts fed Claude Science a detailed prompt of ~35 pages .

Source: Crypto Briefing